PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

We are a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. Our products and technology, which include our HiFi long-read sequencing technology, address a broad set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Our focus is on creating some of the world's most advanced sequencing systems to provide our customers with the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations ("CROs"), pharmaceutical companies, and agricultural companies. Recent Developments On January 30, 2026, we completed the disposition of assets to Illumina Cambridge Limited (the Buyer ) in accordance with the terms of an Asset Purchase Agreement, dated January 30, 2026 (the Asset Purchase Agreement ), by and among us, Buyer, and Illumina, Inc.